Methylphenidate HCl or Modafinil in Treating Young Patients With Excessive Daytime Sleepiness After Cancer Therapy

NCT01348607 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study only randomized 1 subject and was determined not feasible by DSMB

Conditions

Central Nervous System Tumor, Pediatric
Fatigue
Specific Disorders of Sleep

Interventions

DRUG: methylphenidate hydrochloride
DRUG: modafinil
DRUG: placebo

Sponsor

University of South Florida

Collaborators

[object Object]